CompletedPHASE2, PHASE3NCT03087955

Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense

Studying African trypanosomiasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Drugs for Neglected Diseases
Principal Investigator
Victor Kande Betu Kumeso, Dr
Ministère de la Santé, The Democratic Republic of the Congo
Intervention
Acoziborole(drug)
Enrollment
208 enrolled
Eligibility
15 years · All sexes
Timeline
20162020

Study locations (12)

Collaborators

Bill and Melinda Gates Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03087955 on ClinicalTrials.gov

Other trials for African trypanosomiasis

Additional recruiting or active studies for the same condition.

See all trials for African trypanosomiasis

← Back to all trials